Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Plants in Cobb County and Covington have been the subject of lawsuits by cancer patients claiming the release of ethylene ...

A team of scientists led by University of Akron professor Ali Dhinojwala, has created a new adhesive called BEVA 371 Akron, designed to replace the long-standing BEVA 371 adhesive, which has been ...

Material: ethylene-vinyl acetate copolymer, with fast adhesion, high strength, aging resistance, non-toxicity, strong thermal stability, film toughness, etc.